Prescription

MRD / Regn No.

: 20240000164

Date

: 20/07/2026

Patient Name

: Mohammad Alauddin

Age & Gender

: 49 Yrs. / Male

Contact No.

: 1713163135

UHID

:

Ht / Wt / BMI

:

BP S / BP D

:

Allergies

: NKA

Referred By

:

Problem List	:	TYPE 2 DM (28/Feb/2011) \| HYPOGONADOTROPIC HYPOGONADISM (05/Mar/2024) \|
Subjective	:	BANGLADESH,TYPE 2 DM FROM 2011,NO IMPROVEDMENT IN ED
Objective	:	NONE
Analysis	:	TYPE 2 DM,HYPOGONADISM,VITAMIN D DEFICIENCY,ED IMPROVED
Plan	:	REDUCE INSULIN TO 12 UNITS,INCREASE MOUNJARO TO 7.5 MG,SEE ME IN 2 MONTHS WITH TESTING
Salient Investigations	:	FASTING PLASMA GLUCOSE (FPG): 120 mg/dL \| POST PRANDIAL GLUCOSE (2HPP): 135 mg/dL \| GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.6 % \| HDL HIGH DENSITY LIPOPROTEIN: 33 mg/dL \| LDL LOW DENSITY LIPOPROTEIN: 59 mg/dL \| TGL TRIGLYCERIDE: 165 mg/dL \| TOTAL CHOLESTEROL: 103 mg/dl \| VLDL: 33 mg/dl

S#	Generic (Trade) Name	Route	Dosage	Usage	Duration
1	GLARGINE (INJ U100) LANTUS (INJ)		0-0-12 UNITS	AT BEDTIME	TILL NEXT VISIT

2	TABLET DAPAGLIFLOZIN METFORMIN 10 /1000 MG XIG DUO 10 /1000 MG Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION	PO	1-0-0	BEFORE FOOD	TILL NEXT VISIT
	COMBINATION OF METFORMIN AND DAPAGLIFLOZIN MAY CAU...

3	ROSUVASTATIN 10 MG ROSEDAY 10 MG Medicine For CHOLESTEROL	PO	0-0-1	AT BEDTIME	TILL NEXT VISIT
	MAY CAUSE FATIGUE AND MUSCLE PAIN

4	CAPSULE CHOLECALCIFEROL 2000 IU D RISE Medicine For VITAMIN D	PO	0-0-1	AT BEDTIME	TILL NEXT VISIT

5	INJ TESTOSTERONE 250 MG TESTOVIRON 250 MG		Q 3 WEEKS	AS DIRECTED	TILL NEXT VISIT

6	TADALAFIL CITRATE 5 MG MODULA 5 MG Medicine For ERECTILE DYSFUNCTION	PO	0-0-1	AT BEDTIME	TILL NEXT VISIT
	NOT TO BE TAKEN IF WITH NITRATE GROUP OF DRUGS (HEART)

7	INJECTION TIRZEPATIDE 7.5 MG MOUNJARO Medicine For DIABETES OBESITY	SQ	ONCE A WEEK	AS DIRECTED NO RELATION TO FOOD	TILL NEXT VISIT
	MAY CAUSE NAUSEA VOMITING

Refill : 0 / Substitution:

Education

:

Next Visit

: 18/Sep/2026

Tests Suggested For Next Visit

: FBS 2HPP SMBG HBA1C